This discussion draft reflects bipartisan efforts to develop consensus policy proposals regarding appropriate regulation of pharmaceutical compounding. Our goal is to solicit feedback on the policy merits, potential unintended consequences, and potential opportunities to improve the legislative language. The discussion draft is available below. Please submit your written comments to email@example.com by 6 PM on May 3, 2013.
Please click here to see the discussion draft.
Please click here to see the section by section.
Please click here to see the one-pager.